← Peptide library
Peptide blend
KLOW adds the anti-inflammatory tripeptide KPV to the GLOW stack (GHK-Cu, BPC-157, TB-500) — four research peptides run together for skin, gut, and recovery. This page collects the reconstitution and same-syringe co-draw math for the stack, plus the reference status of each. Reference only — not medical advice or a recommendation to use any of them.
INTERACTIVE
Plan the KLOW co-draw
Reconstitute each of the four peptides in its own vial, then plan the same-syringe co-draw — the tool works out the concentration and U-100 units to draw for each. All four are set below; edit the vial size, water, and dose to match your own. Arithmetic only — not medical advice.
KLOW (KPV + GHK-Cu + BPC-157 + TB-500) co-draw calculator X
Reconstitute each vial, then plan the same-syringe co-draw and read U-100 units for each.
Arithmetic checks out. Confirm clinically, against the label, and against the actual vial before any use.
Independent check - dose mg / concentration mg/mL = volume. U-100 units = mL x 100.
Same-syringe co-draw. Reconstitute each peptide in its own vial, then draw them into one syringe.
- Reconstitute each peptide in its own vial — never add water to multiple peptides in one vial.
- Only co-draw peptides with the same diluent (e.g. both bacteriostatic water) and compatible pH.
- Draw and inject fresh — do not pre-mix and store; mixture stability is not established.
- No blended stack is clinically validated. Verify each component and confirm with a clinician.
How the KLOW stack is used
KLOW blends KPV, GHK-Cu, BPC-157, and TB-500 — an anti-inflammatory tripeptide, a copper peptide, and two repair peptides — on the rationale that they support skin, gut, and tissue recovery through different mechanisms. That rationale rests on anecdote and animal or cell data, not human trials: none of the four is FDA-approved for these uses, KPV’s anti-inflammatory effects have only been shown in in-vitro and animal models, the FDA reports limited safety information for BPC-157, and it lists the TB-500 (LKKTETQ) fragment as a potential significant compounding safety risk. No blended stack is clinically validated. The figures here are reconstitution and co-draw arithmetic only — not a dose recommendation or a claim that the stack is safe or effective.
Reference and arithmetic only. Not medical advice; verify with a clinician, product label, pharmacist, or approved research protocol.
Frequently asked questions
How is the KLOW stack administered?
None of the four peptides has an established human treatment route or regimen. All are research peptides that are not FDA-approved for these uses, and the FDA has flagged safety concerns — including listing the TB-500 fragment as a potential significant compounding safety risk. The co-draw planner shows the arithmetic only.
What is the KLOW peptide blend?
KLOW is an informal combination of four research peptides — KPV, GHK-Cu, BPC-157, and TB-500 — essentially the GLOW blend plus KPV, run together for skin, gut, and recovery. It has no established human dose range, so none is quoted here. The calculator still performs the reconstitution and co-draw arithmetic for whatever inputs you enter; it does not tell you what dose to take.
Can I calculate reconstitution for all four here?
Yes — the co-draw planner reconstitutes each peptide in its own vial and shows the concentration (mg/mL), draw volume, and U-100 syringe units for each, plus the combined draw. It is arithmetic only.
Does this page recommend the stack?
No. It is a neutral reference that reflects the limited information available, and it does not assess the safety, efficacy, or suitability of the stack for anyone. Consult a qualified professional.